INNOVATION IN CNS EXPERIMENTAL MEDICINE

P1vital is a Contract Research Organisation specialising in Experimental Medicine for Central Nervous System (CNS) disorders. The company provides a world class contract research service that enables client companies to make more rapid and effective decisions in Phase 1 and Phase 2 clinical development of drugs for CNS disorders.

P1vital has established a pre-competitive consortium with AstraZeneca, GlaxoSmithKline, Lundbeck, Organon – part of Schering-Plough and Wyeth to establish and validate healthy volunteer CNS Experimental Medicine models. The consortium combines the expertise of P1vital, Pharma and academic clinical research teams in a highly innovative approach to the development of new treatments for psychiatric disorders.Read more on the P1vital consortium    -   see our consortium press release